Blueprint Medicines Co. (NASDAQ:BPMC) Stock Position Boosted by Nuveen Asset Management LLC
Nuveen Asset Management LLC increased its stake in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 49.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 419,190 shares of the biotechnology company’s stock after acquiring an additional 138,176 shares during the […]
